IJMS | Free Full-Text | Deciphering the Immunomodulatory Role of Cyclin-Dependent Kinase 4/6 Inhibitors in the Tumor Microenvironment
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment | Nature Reviews Clinical Oncology
Frontiers | Breast Cancer Resistance to Cyclin-Dependent Kinases 4/6 Inhibitors: Intricacy of the Molecular Mechanisms
The application and prospect of CDK4/6 inhibitors in malignant solid tumors | Journal of Hematology & Oncology | Full Text
Potential combination strategies for CDK4/6 inhibitors. CDK4/6... | Download Scientific Diagram
Targeting CDK4/6 in patients with cancer - ScienceDirect
Frontiers | CDK4/6 Inhibitors in Combination Therapies: Better in Company Than Alone: A Mini Review
Frontiers | CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors
Cellular mechanisms underlying response and resistance to CDK4/6 inhibitors in the treatment of hormone receptor-positive breast cancer | Breast Cancer Research | Full Text
IJMS | Free Full-Text | Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration
Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma | Nature Reviews Urology
IJMS | Free Full-Text | CDK4/6 Inhibitor Resistance in Hormone Receptor-Positive Metastatic Breast Cancer: Translational Research, Clinical Trials, and Future Directions
Liquid biopsies to predict CDK4/6 inhibitor efficacy and resistance in breast cancer
Targeting CDK4/6 reorganizes chromatin | Nature Cancer
Discovery, Optimization, and Evaluation of Selective CDK4/6 Inhibitors for the Treatment of Breast Cancer | Journal of Medicinal Chemistry
Treating cancer with selective CDK4/6 inhibitors | Nature Reviews Clinical Oncology
IJMS | Free Full-Text | The Therapeutic Potential of CDK4/6 Inhibitors, Novel Cancer Drugs, in Kidney Diseases
AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers | npj Precision Oncology
The Strange Case of CDK4/6 Inhibitors: Mechanisms, Resistance, and Combination Strategies: Trends in Cancer
Senescence as a therapeutically relevant response to CDK4/6 inhibitors | Oncogene
Biomedicines | Free Full-Text | Targeting CDK4/6 for Anticancer Therapy
Targeting CDK4/6 pathways and beyond in breast cancer - ScienceDirect
Diagnostics | Free Full-Text | Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer—A Review of the Literature
Mechanisms that underlie resistance to CDK4/6 inhibitors. (Adapted and... | Download Scientific Diagram
